| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |